"Healthcare" on Cryptosearcher: the stories, the context, and what they actually mean.
Moderna's stock rose 4% after Health Canada authorized the first human trial of its Bundibugyo Ebola vaccine candidate. The study will test safety and immune response in roughly 80 healthy volunteers across Canada.
August 5, 2026
July 29, 2026
July 25, 2026